Literature DB >> 28655610

Neuropeptide S (NPS) is a neuropeptide with cellular actions in arousal and anxiety-related nuclei: Functional implications for effects of NPS on wakefulness and mood.

Vincenzo Roncacè1, Filip Souza Polli1, Minella Zojicic1, Kristi A Kohlmeier2.   

Abstract

Neuropeptide S (NPS) is a peptide recently recognized to be present in the CNS, and believed to play a role in vigilance and mood control, as behavioral studies have shown it promotes arousal and has an anxiolytic effect. Although NPS precursor is found in very few neurons, NPS positive fibers are present throughout the brain stem. Given the behavioral actions of this peptide and the wide innervation pattern, we examined the cellular effects of NPS within two brain stem nuclei known to play a critical role in anxiety and arousal: the dorsal raphe (DR) and laterodorsal tegmentum (LDT). In mouse brain slices, NPS increased cytoplasmic levels of calcium in DR and LDT cells. Calcium rises were independent of action potential generation, reduced by low extracellular levels of calcium, attenuated by IP3 - and ryanodine (RyR)-dependent intracellular calcium store depletion, and eliminated by the receptor (NPSR) selective antagonist, SHA 68. NPS also exerted an effect on the membrane of DR and LDT cells inducing inward and outward currents, which were driven by an increase in conductance, and eliminated by SHA 68. Membrane actions of NPS were found to be dependent on store-mediated calcium as depletion of IP3 and RyR stores eliminated NPS-induced currents. Finally, NPS also had actions on synaptic events, suggesting facilitation of glutamatergic and GABAergic presynaptic transmission. When taken together, actions of NPS influenced the excitability of DR and LDT neurons, which could play a role in the anxiolytic and arousal-promoting effects of this peptide.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brain slices; Mouse; REM sleep; Stress

Mesh:

Substances:

Year:  2017        PMID: 28655610     DOI: 10.1016/j.neuropharm.2017.06.025

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  2 in total

1.  Central noradrenergic activity affects analgesic effect of Neuropeptide S.

Authors:  Kei Jinushi; Tetsuya Kushikata; Takashi Kudo; Girolamo Calo; Remo Guerrini; Kazuyoshi Hirota
Journal:  J Anesth       Date:  2017-11-11       Impact factor: 2.078

2.  Neuropeptide S Receptor Stimulation Excites Principal Neurons in Murine Basolateral Amygdala through a Calcium-Dependent Decrease in Membrane Potassium Conductance.

Authors:  Sion Park; Pia Flüthmann; Carla Wolany; Lena Goedecke; Hannah Maleen Spenner; Thomas Budde; Hans-Christian Pape; Kay Jüngling
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.